Immune Training MS trial 'safe'
An experimental treatment to stop the body attacking its own nervous system in patients with multiple sclerosis (MS) appears safe in trials.
The sheath around nerves cells, made of myelin, is destroyed in MS, leaving the nerves struggling to pass on messages.
A study on nine patients, reported in Science Translational Medicine, tried to train the immune system to cease its assault on myelin.
The MS Society said the idea had "exciting potential".
As nerves lose their ability to talk to each other, the disease results in problems moving and balancing and can affect vision.
There are drugs that can reduce number and severity of attacks, but there is no cure.
To read the full article click here.
- Jun 2021 (1)
- Feb 2020 (1)
- Apr 2018 (1)
- Mar 2018 (1)
- Jan 2018 (3)
- Dec 2017 (5)
- Nov 2017 (7)
- Oct 2017 (8)
- Sep 2017 (8)
- Aug 2017 (4)
- Jul 2017 (5)
- Jun 2017 (5)
- May 2017 (3)
- Apr 2017 (3)
- Mar 2017 (4)
- Feb 2017 (2)
- Jan 2017 (1)
- Dec 2016 (5)
- Nov 2016 (8)
- Oct 2016 (7)
- Sep 2016 (2)
- Aug 2016 (6)
- Jul 2016 (6)
- Jun 2016 (1)
- A Career in Care - Jessica's Story
- Routes Blog 2020!
- Liverpool CQC inspection achieves a Good
- A huge THANK YOU to all our fantastic field and branch staff!
- Recruitment Opportunity in Newcastle
- Preston has moved
- Tameside's Christmas Toy Collection
- Certificate of Inspiration
- Tameside receive an OUTSTANDING in Care
Most Popular Posts
- Healthcare Assistants wanted in Blackpool to care for a gentleman and lady with spinal injuries
- Mental Health campaign receives additional funding
- Routes Healthcare need experienced childminders across the North West of England
- Accounts & Payroll Trainee Vacancy Routes Healthcare - Macclesfield
- Social Worker Struck Off
- Routes Healthcare Blackpool is committed to the modern apprenticeship scheme
- Routes Childcare - The local company with the Worldwide experience!
- Cancer 'Smart Bomb' Successfully Tested in US
- Personalisation 'at high risk of failure', Norman Lamb told
There are currently no comments for this post, use the form below to be the first!.